Literature DB >> 18749717

Intracavitary chemotherapy in ovarian cancer-an investigational procedure.

R F Ozols1.   

Abstract

Entities:  

Year:  1985        PMID： 18749717      PMCID： PMC1306046     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  8 in total

1.  Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.

Authors:  R F Ozols; G Y Locker; J H Doroshow; K R Grotzinger; C E Myers; R C Young
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

2.  Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter.

Authors:  J Jenkins; P H Sugarbaker; F J Gianola; C E Myers
Journal:  Surg Gynecol Obstet       Date:  1982-06

3.  Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.

Authors:  R F Ozols; R C Young; J L Speyer; P H Sugarbaker; R Greene; J Jenkins; C E Myers
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

4.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Authors:  R L Dedrick; C E Myers; P M Bungay; V T DeVita
Journal:  Cancer Treat Rep       Date:  1978-01

5.  Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.

Authors:  J L Speyer; J M Collins; R L Dedrick; M F Brennan; A R Buckpitt; H Londer; V T DeVita; C E Myers
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

6.  High-volume intraperitoneal chemotherapy with methotrexate in patients with cancer.

Authors:  R B Jones; J M Collins; C E Myers; A E Brooks; S M Hubbard; J E Balow; M F Brennan; R L Dedrick; V T DeVita
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

7.  High-dose cisplatin in hypertonic saline.

Authors:  R F Ozols; B J Corden; J Jacob; M N Wesley; Y Ostchega; R C Young
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

8.  Intraperitoneal cisplatin with systemic thiosulfate protection.

Authors:  S B Howell; C L Pfeifle; W E Wung; R A Olshen; W E Lucas; J L Yon; M Green
Journal:  Ann Intern Med       Date:  1982-12       Impact factor: 25.391
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.